TianYu Bio-Technology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	153.39	178.05	151.6	287.73	305.66
Trading Asset Securities	8.43	-	-	-	-
Cash & Short-Term Investments	161.83	178.05	151.6	287.73	305.66
Cash Growth	-9.11%	17.44%	-47.31%	-5.87%	68.44%
Accounts Receivable	405.27	735.89	893.69	1,033	1,382
Other Receivables	122.24	258.93	307.38	294.37	296.99
Receivables	527.51	994.82	1,201	1,327	1,679
Inventory	224.71	223.77	159.63	239.74	105.95
Other Current Assets	212.43	56.16	115.17	59.85	132.42
Total Current Assets	1,126	1,453	1,627	1,914	2,223
Property, Plant & Equipment	533.42	533.56	521.79	361.86	233.26
Long-Term Investments	101.87	97.5	101.67	255.83	96.63
Goodwill	1.52	2.08	5.56	5.56	5
Other Intangible Assets	25.15	26.15	7.12	7.82	104.93
Long-Term Accounts Receivable	-	613.03	452.24	309.12	129.08
Long-Term Deferred Tax Assets	102.05	105.4	109.43	92.12	46.83
Long-Term Deferred Charges	5.62	4.95	5.3	4.65	3.59
Other Long-Term Assets	997.03	279.51	342.06	409.89	486.69
Total Assets	2,893	3,215	3,273	3,461	3,329
Accounts Payable	683.15	638.33	684	666.01	684.18
Accrued Expenses	29.94	28.24	19.38	16.59	6.62
Short-Term Debt	91.08	128.23	168.35	152.76	216.34
Current Portion of Long-Term Debt	193.22	115.51	77.61	39.39	311.02
Current Portion of Leases	-	35.94	25.94	33.71	6.31
Current Income Taxes Payable	3.8	0.05	-	1.35	2.28
Current Unearned Revenue	79.15	144.65	82.5	71.63	80.07
Other Current Liabilities	245.29	255.4	180.37	149.4	117.15
Total Current Liabilities	1,326	1,346	1,238	1,131	1,424
Long-Term Debt	692.14	753.37	751.37	649.16	212.11
Long-Term Leases	64.76	247.13	281.18	209.79	41
Long-Term Unearned Revenue	0.61	0.69	-	-	-
Long-Term Deferred Tax Liabilities	2.45	2.68	0.07	0.26	0.58
Other Long-Term Liabilities	213.91	156.24	167.5	36.79	39.59
Total Liabilities	2,299	2,506	2,438	2,027	1,717
Common Stock	290.15	290.15	290.15	290.15	290.15
Additional Paid-In Capital	912.8	912.21	931.77	931.9	930.16
Retained Earnings	-790.52	-683.62	-576.26	-81.85	197.55
Total Common Equity	412.42	518.74	645.66	1,140	1,418
Minority Interest	181.22	189.79	188.69	293.53	193.73
Shareholders' Equity	593.64	708.53	834.35	1,434	1,612
Total Liabilities & Equity	2,893	3,215	3,273	3,461	3,329
Total Debt	1,041	1,280	1,304	1,085	786.78
Net Cash (Debt)	-879.37	-1,102	-1,153	-797.09	-481.12
Net Cash Per Share	-3.03	-3.80	-3.97	-3.30	-1.81
Filing Date Shares Outstanding	-	290.15	290.15	290.15	290.15
Total Common Shares Outstanding	-	290.15	290.15	290.15	290.15
Working Capital	-199.15	106.45	389.31	783.56	798.86
Book Value Per Share	-	1.79	2.23	3.93	4.89
Tangible Book Value	385.76	490.5	632.98	1,127	1,308
Tangible Book Value Per Share	-	1.69	2.18	3.88	4.51
Buildings	-	150.56	98.24	7.96	176.46
Machinery	-	245.82	209.27	88.56	31.86
Construction In Progress	-	21.37	19.06	7.37	3.93

Source: S&P Global Market Intelligence. Standard template. Financial Sources.